Zobrazeno 1 - 8
of 8
pro vyhledávání: '"hartaandoeningen"'
Autor:
Michiel F. Reneman, Frederik Keus, Willem Dieperink, Iwan C. C. van der Horst, Fredrike Blokzijl, Massimo A. Mariani, Marisa Onrust, Wolter Paans
Publikováno v:
Journal of Occupational Rehabilitation
Journal of Occupational Rehabilitation, 31(2), 316-322. Springer
Journal of Occupational Rehabilitation. Kluwer
Journal of Occupational Rehabilitation, 31. SPRINGER/PLENUM PUBLISHERS
Journal of Occupational Rehabilitation, 31(2), 316-322. Springer
Journal of Occupational Rehabilitation. Kluwer
Journal of Occupational Rehabilitation, 31. SPRINGER/PLENUM PUBLISHERS
Purpose Coronary artery bypass grafting is the most frequently performed cardiac surgical procedure. Despite its benefits on survival and quality of life, it is associated with a considerable financial burden on society including sick leave. Our stud
Publikováno v:
Journal of Occupational Rehabilitation.
Coronary artery bypass grafting is the most frequently performed cardiac surgical procedure. Despite its benefits on survival and quality of life, it is associated with a considerable financial burden on society including sick leave. Our study aimed
Autor:
van Marion, Denise M.S., Hu, Xu, Zhang, Deli, Hoogstra-Berends, Femke, Seerden, Jean Paul G., Loen, Lizette, Heeres, Andre, Steen, Herman, Henning, Robert H., Brundel, Bianca J.J.M.
Publikováno v:
Drug Design, Development and Therapy, 13. Dove Press Limited
Drug Design, Development and Therapy, 13, 345-364. DOVE MEDICAL PRESS LTD
van Marion, D M S, Hu, X, Zhang, D, Hoogstra-Berends, F, Seerden, J-P G, Loen, L, Heeres, A, Steen, H, Henning, R H & Brundel, B J J M 2019, ' Screening of novel HSP-inducing compounds to conserve cardiomyocyte function in experimental atrial fibrillation ', DRUG DESIGN DEVELOPMENT AND THERAPY, vol. 13, pp. 345-364 . https://doi.org/10.2147/DDDT.S176924
Drug Design, Development and Therapy, 13, 345-364
DRUG DESIGN DEVELOPMENT AND THERAPY, 13, 345-364. Dove Medical Press Ltd.
Drug Design, Development and Therapy 13 (2019)
Drug Design, Development and Therapy, 13, 345-364. DOVE MEDICAL PRESS LTD
van Marion, D M S, Hu, X, Zhang, D, Hoogstra-Berends, F, Seerden, J-P G, Loen, L, Heeres, A, Steen, H, Henning, R H & Brundel, B J J M 2019, ' Screening of novel HSP-inducing compounds to conserve cardiomyocyte function in experimental atrial fibrillation ', DRUG DESIGN DEVELOPMENT AND THERAPY, vol. 13, pp. 345-364 . https://doi.org/10.2147/DDDT.S176924
Drug Design, Development and Therapy, 13, 345-364
DRUG DESIGN DEVELOPMENT AND THERAPY, 13, 345-364. Dove Medical Press Ltd.
Drug Design, Development and Therapy 13 (2019)
Denise MS van Marion,1,* Xu Hu,1,* Deli Zhang,1 Femke Hoogstra-Berends,2 Jean-Paul G Seerden,3 Lizette Loen,3 Andre Heeres,3,4 Herman Steen,5 Robert H Henning,2 Bianca JJM Brundel1 1Department of Physiology, Amsterdam Cardiovascular Sciences, VU Univ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::388f03a446951c4da51fc1690bc4f52a
https://research.hanze.nl/en/publications/ef625647-f175-46f9-936c-7670b3195a54
https://research.hanze.nl/en/publications/ef625647-f175-46f9-936c-7670b3195a54
Background: The heat shock protein (HSP) inducer, geranylgeranylacetone (GGA), was previously found to protect against atrial fibrillation (AF) remodeling in experimental model systems. Clinical application of GGA in AF is limited, due to low systemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::41fbd5b302e8670c3bcabee9f85cfc38
Publikováno v:
Congenital Heart Disease. 8(2):38-44
OBJECTIVE: To examine the willingness of grown-ups with congenital heart disease (GUCH) to participate in the GUCH Training Program-Individualised (GTI), an exercise program specifically designed for GUCH, and to identify factors affecting their will
Heat Shock Protein–Inducing Compounds as Therapeutics to Restore Proteostasis in Atrial Fibrillation
Autor:
Bianca J. J. M. Brundel, Jean-Paul G. Seerden, Femke Hoogstra-Berends, Roelien A. M. Meijering, Lizette Loen, Robert H. Henning, Harm H. Kampinga, Irma Kuipers, Deli Zhang, André Heeres
Publikováno v:
Trends in Cardiovascular Medicine, 22(3), 62-68
Trends in Cardiovascular Medicine, 22(3), 62-68. Elsevier
Trends in Cardiovascular Medicine 22 (2012) 3
Hoogstra-Berends, F, Meijering, R A M, Zhang, D, Heeres, A, Loen, L, Seerden, J-P, Kuipers, I, Kampinga, H H, Henning, R H & Brundel, B J J M 2012, ' Heat Shock Protein-Inducing Compounds as Therapeutics to Restore Proteostasis in Atrial Fibrillation ', Trends in cardiovascular medicine, vol. 22, no. 3, pp. 62-68 .
Trends in Cardiovascular Medicine, 22(3), 62-68. Elsevier
Trends in Cardiovascular Medicine 22 (2012) 3
Hoogstra-Berends, F, Meijering, R A M, Zhang, D, Heeres, A, Loen, L, Seerden, J-P, Kuipers, I, Kampinga, H H, Henning, R H & Brundel, B J J M 2012, ' Heat Shock Protein-Inducing Compounds as Therapeutics to Restore Proteostasis in Atrial Fibrillation ', Trends in cardiovascular medicine, vol. 22, no. 3, pp. 62-68 .
Atrial fibrillation (AF) is the most common clinical tachyarrhythmia associated with significant morbidity and mortality and is expected to affect approximately 30 million North Americans and Europeans by 2050. AF is a persistent disease, caused by p
Autor:
Mathieu H. G. de Greef, Isabelle C. Van Gelder, Miriam van Ittersum, Cees P. van der Schans, Johan Brügemann, Jenifer E. Coster
Publikováno v:
International Journal of Rehabilitation Research, 26(2), 117-122. LIPPINCOTT WILLIAMS & WILKINS
International Journal of Rehabilitation Research, 26(2), 117-122. Lippincott, Williams & Wilkins
International Journal of Rehabilitation Research, 26(2), 117-122. Lippincott, Williams & Wilkins
Several studies have reported improved survival rates thanks to the use of an implantable cardioverter defibrillator (ICD) in the treatment of patients with life-threatening arrhythmia. However, the effects of the ICD on health-related quality of lif
Autor:
Dontje, Manon L., Feenstra, Marlies, de Greef, Mathieu H. G., Nieuwland, Wybe, Hoendermis, Elke S.
Publikováno v:
Congenital Heart Disease, 8(2), 38-44. Wiley-Blackwell
Congenital heart disease, 9(1), 38-44. Wiley-Blackwell
Congenital heart disease, 9(1), 38-44. Wiley-Blackwell
ObjectiveTo examine the willingness of grown-ups with congenital heart disease (GUCH) to participate in the GUCH Training Program-Individualised (GTI), an exercise program specifically designed for GUCH, and to identify factors affecting their willin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cc03fcb447cb526234e905db44b51d48
https://research.hanze.nl/en/publications/1bb3af0d-6ce5-4454-ab2f-06c8189f5844
https://research.hanze.nl/en/publications/1bb3af0d-6ce5-4454-ab2f-06c8189f5844